<--- Back to Details
First PageDocument Content
Biology / Molecular biology / Escherichia coli / Biotechnology / DNA / AB5 toxins / Shigatoxigenic and verotoxigenic Escherichia coli / Single-nucleotide polymorphism / Hemolytic-uremic syndrome / Shiga toxin / SNP genotyping / Multilocus sequence typing
Biology
Molecular biology
Escherichia coli
Biotechnology
DNA
AB5 toxins
Shigatoxigenic and verotoxigenic Escherichia coli
Single-nucleotide polymorphism
Hemolytic-uremic syndrome
Shiga toxin
SNP genotyping
Multilocus sequence typing

Letter Probing genomic diversity and evolution of Escherichia coli O157 by single nucleotide polymorphisms Wei Zhang,1,5,6 Weihong Qi,2 Thomas J. Albert,3 Alifiya S. Motiwala,4 David Alland,4

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Download Document from Source Website

File Size: 468,08 KB

Share Document on Facebook

Similar Documents

Biotechnology, BS

Biotechnology, BS "DBEFNJD.BQ  5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT

DocID: 1xTqy - View Document

PDF Document

DocID: 1wroO - View Document

Building A Better Mousetrap:  Patenting Biotechnology In The European Community

Building A Better Mousetrap: Patenting Biotechnology In The European Community

DocID: 1vr7C - View Document

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

DocID: 1vq6b - View Document

Biotechnology Consultation Agency Response Letter BNF

Biotechnology Consultation Agency Response Letter BNF

DocID: 1vpUZ - View Document